Activities of Mutant Prevention Concentration-Targeted Moxifloxacin and Levofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model

Podobne zapisy

• Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of Infection
  od: Lacy, Melinda K., i wsp.
  Wydane: (1999)
• Pharmacodynamics of Moxifloxacin and Levofloxacin at Simulated Epithelial Lining Fluid Drug Concentrations against Streptococcus pneumoniae
  od: Florea, Naomi R., i wsp.
  Wydane: (2004)
• Pharmacodynamics of Moxifloxacin against Streptococcus pyogenes in an In Vitro Kinetic Model
  od: Odenholt, Inga, i wsp.
  Wydane: (2002)
• Linezolid and Vancomycin, Alone and in Combination with Rifampin, Compared with Moxifloxacin against a Multidrug-Resistant and a Vancomycin-Tolerant Streptococcus pneumoniae Strain in an In Vitro Pharmacodynamic Model
  od: Cha, Raymond, i wsp.
  Wydane: (2003)
• Activities of Newer Fluoroquinolones against Ciprofloxacin-Resistant Streptococcus pneumoniae
  od: Coyle, Elizabeth A., i wsp.
  Wydane: (2001)